SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine
Clinical trial NCT04952402 · COMPLETED
Trial details
- NCT number
- NCT04952402
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-09
- Primary completion
- 2022-02-28
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.